Navigation Links
Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
Date:10/29/2008

biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at http://www.telik.com.

This press release contains "forward-looking" statements. These include statements concerning the potential for TELCYTA to treat ovarian cancer and the effectiveness of TELCYTA in combination with PLD and in patients under certain platinum refractory and platinum resistant conditions. These forward-looking statements are based upon Telik's current expectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including the risks associated with clinical trials and the interpretation of resulting data. Detailed information regarding these and other factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the quarter ended June 30, 2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA, and TRAP are trademarks or registered trademarks of Telik, Inc. '/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
2. Telik Announces Receipt of Nasdaq Notice
3. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
4. ReceptorBio Announces Diabetes License Agreement With Telik
5. Telik Announces Financial Results For 2008 Second Quarter
6. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
7. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
8. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
9. Telik Announces First Quarter 2008 Financial Results
10. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
11. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotec... virus, genomic data from the 1918 pandemic throug...rrent H1N1 pandemic, today issued its latest bioch...hat the lethality of the H1N1 ("Swine Flu") virus ... the virus,s current outbreak in the spring of 200...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia...per and provider of vaccines, announced today that...ablish Sinovac (Dalian) Vaccine,Technology Co., Lt..., produce,and commercialize human-use vaccines. Si... in developing and commercializing world-class vac...
(Date:11/24/2009)... , HOUSTON, Nov. 24 /PRNewswire-FirstCall/ ...er of electrical and communications systems and se...ial markets, announced today that its commercial b...hattan Torcon JV to install the electrical systems...t facility at the U.S. Army Medical Research Insti...
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNe...nced today it is acquiring the assets of Hyland Se...Ontario. The addition of Hyland Seeds will further...s the company anticipates the introduction of Sma...cide Tolerant Trait Technology in corn in 2012. Th...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...izing targeted direct-mail marketing, Middleton-ba...s brought a Midwestern health care provider unexpe...-care physician, 505 overall new patients and $152... management solutions for health care. , ,With adv...ve segmentation to narrow audiences, direct mail b...
...Wisconsins biotechnology sector and other well-est...icle in Genetic Engineering News featuring Wisco...s credit where its due, say technology leaders. , ...ericas biotechnology centers, and while they conti...g up. According to the article, Wisconsins 150-plu...
...enforcement agencies are slated to begin training ...d identify criminals. The training, sponsored by t...rix FACES system. The system allows photo-like im...er by selecting from a database of 4,400 facial fe...CES, which is also used by the CIA and FBI, compos...
Other Biology Technology:Wisconsin's biotech industry recognized by national publication 2
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
(Date:11/24/2009)...eakened and flabby arteries from collapsing have b...stents are no longer needed -- once the arteries a...ly, doctors had no choice but to leave them in pla...ity,s Department of Biomedical Engineering has dev...rries drugs where they,re needed, then dissolves. ...
(Date:11/24/2009)...W YORK (November 24, 2009) -- The Wildlife Conserv...ling that the last remaining population of Siberia...the rising tide of poaching and habitat loss. , ...ussian officials of what needs to be done to prote...t. , The report was released by the...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2WellNet Healthcare Names Chris Kaiser and Jay Thompson Sales Executives 49020 1WellNet Healthcare Names Chris Kaiser and Jay Thompson Sales Executives 49020 2Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 1Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 2Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement 49016 1Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement 49016 2
... movement of cells within the body during growth, ...vading pathogens, has been demonstrated by researc...CSD) School of Medicine. Published in the March 27...rnal,s upcoming April print edition, the study des...hesion receptor with a protein called paxillin cre...
...ble and obvious as “going gray,?yet scientists hav... usually unwelcome transformation.,In a report pos...researchers from Dana-Farber Cancer Institute and ... cellular cause of graying hair while,investigatin...ly deadly,skin cancer. , The,scientists traced the...
...ing to fully understand a particular communication...malignant brain and prostate cancers. While scient...er key components have remained a mystery. Researc...missing puzzle piece, a finding that may present d..., "We believe that we have identified a component ...
Other Biology News:Vital step in cellular migration described by UCSD medical researchers 2Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 2Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 3Researchers identify target for cancer drugs 2
...ood bank refrigerators: ,Each upright model provi... superior 4C temperature uniformity for refrigerat...2000 Surveillance Module for complete blood storag... are equipped with the HemaPro 101 alarm/monitor. ...
SuperScript III RNase H- Reverse Transcriptase from Invitrogen
4" Riser for 16" Tanks (for use with 4000108 and 4000109) from Thermo Scientific
Rapid DNA Ligation Kit from Roche Applied Science
Biology Products: